Measures of postural steadiness are used to characterize the dynamics of the postural control system associated with maintaining balance during quiet standing. The objective of this study was to evaluate the relative sensitivity of center-of-pressure (COP)-based measures to changes in postural steadiness related to age. A variety of time and frequency domain measures of postural steadiness were compared between a group of twenty healthy young adults (21-35 years) and a group of twenty healthy elderly adults (66-70 years) under both eyes-open and eyes-closed conditions. The measures that identified differences between the eyes-open and eyes-closed conditions in the young adult group were different than those that identified differences between the eye conditions in the elderly adult group. Mean velocity of the COP was the only measure that identified age-related changes in both eye conditions, and differences between eye conditions in both groups. The results of this study will be useful to researchers and clinicians using COP-based measures to evaluate postural steadiness.

Recent research has emphasized the importance of the metabolic cluster, which includes glucose intolerance, dyslipidemia, and high blood pressure, as a strong predictor of the obesity-related morbidities and premature mortality. Fundamental to this association, commonly referred to as the metabolic syndrome, is the close interaction between abdominal fat patterning, total body adiposity, and insulin resistance. As the initial step in identifying major genetic loci influencing these phenotypes, we performed a genomewide scan by using a 10-centiMorgan map in 2,209 individuals distributed over 507 nuclear Caucasian families. Pedigreebased analysis using a variance components linkage model demonstrated a quantitative trait locus (QTL) on chromosome 3 (3q27) strongly linked to six traits representing these fundamental phenotypes [logarithm of odds (lod) scores ranged from 2.4 to 3.5]. This QTL exhibited possible epistatic interaction with a second QTL on chromosome 17 (17p12) strongly linked to plasma leptin levels (lod ‫؍‬ 5.0). Situated at these epistatic QTLs are candidate genes likely to influence two biologic precursor pathways of the metabolic syndrome. O besity is a common and chronic disorder associated with decreased longevity and increased morbidity from a variety of diseases, including type 2 diabetes mellitus, hypertension, stroke, and coronary heart disease (1). Fat distribution, specifically the pattern known as upper-body, abdominal, or visceral obesity, is a major predictor of the adverse metabolic profile predisposing to these health risks (2). Thus, abdominal-visceral fat size has emerged as a significant precursor of glucose intolerance, hyperinsulinemia, elevated plasma triglycerides, decreased high density lipoprotein-cholesterol, and increased blood pressure (3). Fundamental to this metabolic milieu are close interactions between total body adiposity, abdominalvisceral fat size, and insulin resistance. Reaven (4) provided evidence to suggest that resistance to insulin-stimulated glucose uptake is associated with a series of related metabolic variables, termed ''syndrome X,'' which cluster in the same individual and include glucose intolerance, disturbed plasma lipids, and high blood pressure (4). Because of close similarities of these features with those associated with abdominal obesity, the more collective term metabolic syndrome was introduced (5).The etiology of the abdominal obesity-metabolic syndrome is complex and is thought to involve metabolic, neuroendocrine, and genetic interactions. A metabolic-neuroendocrine cascade has been proposed in which increased free fatty acid flux from the highly lipolytic visceral adipocytes, together with imbalances in sex hormones, could cause the insulin resistance and hyperinsulinemia, with their metabolic consequences (6). Weight gain with preferential deposition of adipocytes in the abdominal-visceral region is considered secondary to adoption of Westernized diet, activity lifestyle, and reactivity to emotional, intellectual, and physical stresses (5...

No abstract

The identification and characterization of age-related changes in postural steadiness will enhance our understanding of the postural control system, and may help to identify persons at risk for falls in the elderly population. This review includes a discussion of the methods that have been used to evaluate the static (postural steadiness) and dynamic (postural stability) performance of the postural control system. Time and frequency domain measures of postural steadiness are described. Research investigations of age-related changes in the postural control system, with an emphasis on postural steadiness evaluations, are discussed. Control systems and biomechanical models of the postural control system are described. Finally, the evaluation of bilateral asymmetries in postural sway and weight distribution, with a dual force plate balance platform, is briefly discussed. I. INTRODUCTION0 maintain standing balance, the postural control system T integrates information from the visual, vestibular, and proprioceptive systems. If one or more of these systems is impaired as part of the aging process, or in neurologic disease, then the postural control system must adjust the relative weighting factors of the inputs to maintain balance. Several studies have investigated the relative roles of the visual, vestibular, and proprioceptive systems in maintaining balance [12], [23], [59], [73], [95], [97]. Postural control is often discussed in terms of control systems theory [53],[HI, [137]. Johansson [53] reviewed topics related to human postural control, including biomechanics, neurophysiology, postural stability and steadiness, and postural control models.The performance of the postural control system is generally evaluated with measures of postural sway. As Maki summarized [72], postural sway has been characterized by the motion of body segments or joints, joint moments, EMG activity, and displacement of the center-of-pressure (COP) at the feet.

Aims In humans, genetic variation in endocannabinergic signaling has been associated with anthropometric measures of obesity. In randomized trials, pharmacological blockade at the level of the cannabinoid receptor 1 (CNR1) receptor not only facilitates weight reduction, but also improves insulin sensitivity and clinical measures of lipid homeostasis. We therefore tested the hypothesis that genetic variation in CNR1 is associated with common obesity-related metabolic disorders. Materials & methods A total of six haplotype tagging SNPs were selected for CNR1, using data available within the Human HapMap (Centre d’Etude du Polymorphisme Humain population) these included: two promoter SNPs, three exonic SNPs, and a single SNP within the 3′-untranslated region. These tags were then genotyped in a rigorously phenotyped family-based collection of obese study subjects of Northern European origin. Results & conclusions A common CNR1 haplotype (H4; prevalence 0.132) is associated with abnormal lipid homeostasis. Additional statistical tests using single tagging SNPs revealed that these associations are partly independent of body mass index.

No abstract

No abstract

No abstract